April 19, 2019
This one-day conference brings together basic researchers and clinicians with an interest in immunotherapies as promising approaches for patients with different types of cancer. The conference will provide an update on the most recent developments in the field of cancer immunotherapy and it will facilitate collaborative efforts between basic tumor immunologists and oncologists/hematologists using novel immunotherapeutic approaches to the benefit of their patients. This conference will help us to identify the most promising immunotherapies for our patients leading to improved outcomes and maybe even cures.
Marco Ruella, MD, University of Pennsylvania
Lydia Lee, PhD University College London
David Scheinberg, MD, PhD, Memorial Sloan Kettering Cancer Center
Ryan O’Connell, PhD
Trudy Oliver, PhD
Alana Welm, PhD
Djordje Atanackovic, MD
Matthew Van Brocklin, PhD
Brian Evavold, PhD
Siwen Hu-Lieskovan, MD, PhD
Djordje Atanackovic, MD
Special Lunch Event
Vendor Presentation by Carterra
12:15 - 1:15 PM
HCI Research South 1A
This conference is for anyone treating patients with cancer such as medical oncologists, hematologists, surgical oncologists, radiation oncologists, primary care physicians, pharmacists, physician assistants, advanced practice nurses, and nurses. It is also for basic researchers interested in the role of the immune environment in cancer development and progression, the relevance of cancer immunosurveillance, tumor-specific immune responses, and the design of novel cancer immunotherapies.
Accreditation: The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit: The University of Utah School of Medicine designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nondiscrimination and Disability Accommodation Statement: The University of Utah does not exclude, deny benefits to or otherwise discriminate against any person on the basis of race, color, national origin, sex, disability, age, veteran’s status, religion, gender identity/expression, genetic information, or sexual orientation in admission to or participation in its programs and activities. Reasonable accommodations will be provided to qualified individuals with disabilities upon request, with reasonable notice. Requests for accommodations or inquiries or complaints about University nondiscrimination and disability/access policies may be directed to the Director, OEO/AA, Title IX/Section 504/ADA Coordinator, 201 S President’s Circle, RM 135, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax).
Please contact Kiramey Gilleese at firstname.lastname@example.org or 801-213-5750 if you have questions or need additional information.